Market Overview:
The global respiratory disease testing/diagnostics market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of respiratory diseases, rising awareness about respiratory diseases, and technological advancements in respiratory disease testing/diagnostics. The global respiratory disease testing/diagnostics market is segmented by type into imaging test, respiratory measurement, blood gas test, and other tests. The imaging test segment is further sub-segmented into chest X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others. The blood gas test segment is further sub-segmented into arterial blood gas (ABG) analysis and venous blood gas (VBG) analysis. The other tests segment includes sputum cytology examination, nasopharyngeal swab culture & sensitivity test for Streptococcus pneumoniae detection,, polymerase chain reaction assay for Mycobacterium tuberculosis detection,, viral load assay for human immunodeficiency virus 1 (HIV-1) detection,, and others). The global respiratory disease testing/diagnostics market is also segmented by application into hospitals, physician clinics, clinical laboratories, and other applications such as home care settings and long term care facilities.
Product Definition:
Respiratory Disease Testing/Diagnostics is the process of diagnosing and testing respiratory diseases. This is important because it allows healthcare professionals to identify and treat respiratory diseases.
Imaging Test:
Imaging test is a diagnostic procedure that involves the use of X-ray, ultrasound or CT scan. These tests are used to diagnose various respiratory diseases such as pneumonia, bronchitis and other pulmonary disorders. Imaging tests are gaining popularity in medical diagnostics due to its several advantages over traditional diagnostic procedures.
Respiratory Measurement:
Respiratory measurement is a technique used to assess the function of the lungs. It involves using a variety of devices to measure different aspects of respiration such as flow rate, volume, and pattern. Respiratory measurements are commonly performed in pulmonary disease testing/diagnostics or in research settings where an accurate assessment of lung function is required for study purposes.
The global respiratory measurement.
Application Insights:
The other application segment includes research studies. The growing prevalence of chronic respiratory diseases and the rising demand for effective diagnosis methods are expected to drive the market in this segment over the forecast period. For instance, according to a study published by NCBI in 2018, it was found that around 54 million people aged greater than or equal to 15 years have asthma worldwide.
Based on applications, the global market is categorized into hospitals, clinical laboratories and other sites. Hospitals dominated this industry with a revenue share of more than 60% in 2017 owing to an increase in prevalence of chronic respiratory diseases such as asthma and COPD along with an increasing number of hospital-based diagnostic facilities for these disorders.
Regional Analysis:
North America dominated the global respiratory disease testing/diagnostics market in 2016. This can be attributed to favorable reimbursement policies, high prevalence of chronic respiratory diseases, and increasing government initiatives & funding for R&D activities related to respiratory diseases. For instance, in 2014 – 2017 period, the U.S. government invested around USD X billion on research related to infectious disease and around USD X billion on cancer research which is a significant share of overall spending on biomedical & health-related R&D by country (NIH).
Growth Factors:
- Increasing incidence of respiratory diseases
- Growing awareness about respiratory diseases and their diagnosis and treatment
- Rising demand for point-of-care respiratory disease tests
- Technological advancements in respiratory disease testing/diagnostics market
- Increasing number of mergers and acquisitions in the respiratory disease testing/diagnostics market
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Disease Testing/Diagnostics Market Research Report
By Type
Imaging Test, Respiratory Measurement, Blood Gas Test, Other
By Application
Hospitals, Physician Clinics, Clinical Laboratories, Other
By Companies
Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories, Medtronic, NDD Medical Technologies, Nihon Kohden, Philips Medical Systems, SDI Diagnostics, Seegene, Smiths Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Disease Testing/Diagnostics Market Report Segments:
The global Respiratory Disease Testing/Diagnostics market is segmented on the basis of:
Types
Imaging Test, Respiratory Measurement, Blood Gas Test, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Physician Clinics, Clinical Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton Dickinson
- Abbott Laboratories
- Abbott
- Cepheid
- Fischer and Paykel
- Futuremed
- Hoffmann-La Roche
- Instrumentation Laboratories
- Medtronic
- NDD Medical Technologies
- Nihon Kohden
- Philips Medical Systems
- SDI Diagnostics
- Seegene
- Smiths Medical
Highlights of The Respiratory Disease Testing/Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging Test
- Respiratory Measurement
- Blood Gas Test
- Other
- By Application:
- Hospitals
- Physician Clinics
- Clinical Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Disease Testing/Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory disease testing/diagnostics is the process of determining if a person has an infection or illness in their lungs. Tests may include a chest x-ray, sputum test, and lung biopsy.
Some of the major players in the respiratory disease testing/diagnostics market are Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories, Medtronic, NDD Medical Technologies, Nihon Kohden, Philips Medical Systems, SDI Diagnostics, Seegene, Smiths Medical.
The respiratory disease testing/diagnostics market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Disease Testing/Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Disease Testing/Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Disease Testing/Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Disease Testing/Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Disease Testing/Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Respiratory Disease Testing/Diagnostics Market Size and Y-o-Y Growth
4.5.2 Respiratory Disease Testing/Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Respiratory Disease Testing/Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Respiratory Disease Testing/Diagnostics Market Size Forecast by Type
5.2.1 Imaging Test
5.2.2 Respiratory Measurement
5.2.3 Blood Gas Test
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Respiratory Disease Testing/Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Respiratory Disease Testing/Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Physician Clinics
6.2.3 Clinical Laboratories
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Disease Testing/Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Disease Testing/Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Respiratory Disease Testing/Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Respiratory Disease Testing/Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Respiratory Disease Testing/Diagnostics Market Size Forecast by Type
9.6.1 Imaging Test
9.6.2 Respiratory Measurement
9.6.3 Blood Gas Test
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Respiratory Disease Testing/Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Physician Clinics
9.10.3 Clinical Laboratories
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Respiratory Disease Testing/Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Respiratory Disease Testing/Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Respiratory Disease Testing/Diagnostics Market Size Forecast by Type
10.6.1 Imaging Test
10.6.2 Respiratory Measurement
10.6.3 Blood Gas Test
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Respiratory Disease Testing/Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Physician Clinics
10.10.3 Clinical Laboratories
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Respiratory Disease Testing/Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Respiratory Disease Testing/Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Respiratory Disease Testing/Diagnostics Market Size Forecast by Type
11.6.1 Imaging Test
11.6.2 Respiratory Measurement
11.6.3 Blood Gas Test
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Respiratory Disease Testing/Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Physician Clinics
11.10.3 Clinical Laboratories
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Respiratory Disease Testing/Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Respiratory Disease Testing/Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Respiratory Disease Testing/Diagnostics Market Size Forecast by Type
12.6.1 Imaging Test
12.6.2 Respiratory Measurement
12.6.3 Blood Gas Test
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Respiratory Disease Testing/Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Physician Clinics
12.10.3 Clinical Laboratories
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Respiratory Disease Testing/Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Respiratory Disease Testing/Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Respiratory Disease Testing/Diagnostics Market Size Forecast by Type
13.6.1 Imaging Test
13.6.2 Respiratory Measurement
13.6.3 Blood Gas Test
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Respiratory Disease Testing/Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Physician Clinics
13.10.3 Clinical Laboratories
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Disease Testing/Diagnostics Market: Competitive Dashboard
14.2 Global Respiratory Disease Testing/Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton Dickinson
14.3.2 Abbott Laboratories
14.3.3 Abbott
14.3.4 Cepheid
14.3.5 Fischer and Paykel
14.3.6 Futuremed
14.3.7 Hoffmann-La Roche
14.3.8 Instrumentation Laboratories
14.3.9 Medtronic
14.3.10 NDD Medical Technologies
14.3.11 Nihon Kohden
14.3.12 Philips Medical Systems
14.3.13 SDI Diagnostics
14.3.14 Seegene
14.3.15 Smiths Medical
